INS and COVID-19: Previous studies with SARS-CoV-1 showed that ACE-2 was present on pancreatic islets and that infection was associated with hyperglycemia [11], suggesting a possible role for direct cellular damage in COVID-19, leading to acute islet-cell dysfunction, decreased insulin release, and subsequent acute hyperglycemic crisis and even ketosis.